Response Genetics, Inc. Reports Q4 EPS of $(0.07) vs. $(0.08)

Response Genetics Inc. RGDX today announced its consolidated financial results and business progress for the fourth quarter. Total revenue increased by 88 percent to $6.4 million for the fourth quarter ended December 31, 2010, compared to $3.4 million for the same period last year. Response Genetics' net loss for the fourth quarter ended December 31, 2010 was $1.1 million or a loss of $0.06 per share, compared with a net loss of $1.7 million, or a loss of $0.11 per share, for the same period last year. Excluding the net revenue impact of $0.2 million resulting from the conversion to the accrual basis for revenue recognition for ResponseDX™ private payors, the net loss for the three months ended December 31, 2010 was $1.2 million or a loss of $0.07 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!